• Skip to main content
  • Skip to footer
UK Plans to phase out animal testing cnb1662_ec-reg-news_navigation-ad_v2
  • About us
  • News
  • Events
  • Careers
cn-bio-organ-on-a-chip-logo
  • Applications
    • Disease modeling
    • Safety toxicology
    • ADME
  • Services
    • Non-Alcoholic Steatohepatitis
    • Drug-Induced Liver Injury
    • ADME
  • Products
    • PhysioMimix® Core Microphysiological System
    • Consumables
      • PhysioMimix® Multi-chip plates
      • 3D validated cells
    • Organ-on-a-chip models
    • Gut/Liver-on-a-chip
    • Lung-on-a-chip
    • Support packages
  • Technology
  • Resources
  • Company
    • About us
    • Events
    • News
    • Careers in Biotech
  • Contact us

Discover the applications


Investigate the validated core application areas that our PhysioMimix® products and services support

Learn more

Disease modeling

Metabolic dysfunction-associated steatohepatitis
Hepatitis B
Pulmonary infection
Learn more

Safety toxicology

Drug-induced liver injury
Immune-mediated liver injury
Learn more

ADME

Drug absorption
Drug metabolism
Drug bioavailability
Oligonucleotide delivery
Learn more

Studies as a service


Our team will work collaboratively with you to design a study around your research goals and generate actionable data within weeks

Learn more
icon-nash-1-150x150.png MASLD/MASH
icon-dili-tox-150x150.png Drug-induced liver injury
icon-adme-150x150.png ADME

Explore our solutions


PhysioMimix® is a suite of hardware, consumables and assay protocols that enable you to recreate complex human biology and accurately predict human drug responses.

PhysioMimix Core

cnb1476_physiomimix-core_mark_mocks_system_v2
Learn more

Consumables

Multi-chip plates
3D validated cells
Learn more

Models

Single-organ models
- Liver-on-a-chip model
- Lung-on-a-chip model
Multi-organ models
- Gut/Liver-on-a-chip models

Support packages

PhysioMimix® support packages

July 10, 2026

Resource > Posters >

Maximizing data value in MPS ADME experiments using in silico modeling


A model-informed workflow that combines ADME experiments with mechanistic in silico modeling.

Filed under: ADME

cnb1689 maximizing data in silico modeling resource tmb v1 | MPS
View poster

Microphysiological systems (MPS) are increasingly used to generate human-relevant ADME data during drug discovery.

However, experimental design in MPS platforms is constrained by limited working volumes, experimental cost, fixed dosing strategies, and for multi-organ systems, the need to capture interacting kinetic processes such as absorption and metabolism. These constraints often limit the number and timing of samples that can be collected which can lead to lower quality datasets and reduced confidence in parameter estimation.

To maximize the value of MPS experiments, there is a need for model-based approaches as they provide an opportunity to use prior information and a mechanistic understanding of the system to design experiments that extract maximal information from limited datasets.

We have developed a workflow to support planning of PhysioMimix® ADME studies using mechanistic modeling and information-based experimental design. Compound transport and metabolism across MPS compartments are described using ordinary differential equations (ODEs), enabling simulation of concentration–time profiles. Furthermore, the sampling schedules are optimized using a Bayesian approach to best identify parameters such as permeability, efflux ratio and liver clearance – parameters that are important descriptors of a drug’s pharmacokinetics and influence its bioavailability.

View poster

Speak to our experts

Request a meeting with one of our OOC experts to see how our products and services can support your studies

Request a meeting

Footer

CN Bio logo

332 Cambridge Science Park, Milton Road
Cambridge, CB4 0WN

UK: +44 (0) 1223 737 941

US: +1 415 523 4005

Privacy | Cookies | Regulatory | Accessibility
Website terms | Terms of sale

Product Recycling

©2025 CN Bio Innovations Ltd
Registered No. ‍06517359. VAT No. GB978184563

Latest news

  • Organ-on-a-chip trends shaping the next phase of human-relevant R&D from the MPS World Summit 2026 July 6, 2026
  • Which microphysiological system contexts of use are aligned with regulatory roadmaps? June 2, 2026
  • A new era of drug development: Comparing regulatory roadmaps to reduce animal testing June 2, 2026
Cyber Essentials Logo

Modal Title